Kun-Chieh Chen

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2025
Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation.

Mu-Han Peng, Yen-Hsiang Huang, Kuo-Hsuan Hsu

|Jan 21, 2023
Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial.

Heng-Sheng Chao, Chiao-Yun Tsai, Chung-Wei Chou

|Jan 08, 2023
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.

Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu

|Jul 27, 2022
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma.

Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin

|Jun 24, 2022
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid.

Pei-Ya Liao, Wei-Fan Ou, Kang-Yi Su

|Mar 27, 2020
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma.

Lovely Raghav, Ya-Hsuan Chang, Yi-Chiung Hsu

Pageof 1

Frequent Collaborators

2 joint publications

Ho Lin

2 joint publications

Jeng-Sen Tseng

2 joint publications

Gee-Chen Chang

2 joint publications

Tsung-Ying Yang